As of 2025-03-20, the Relative Valuation of Acutus Medical Inc (AFIB) is (42.00) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.09 USD, the upside of Acutus Medical Inc based on Relative Valuation is -46765.4%.
The range of the Relative Valuation is (44.63) - (38.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.6x - 40.5x | 38.6x |
| Forward P/E multiples | 28.8x - 31.8x | 30.3x |
| Fair Price | (44.63) - (38.77) | (42.00) |
| Upside | -49686.6% - -43179.9% | -46765.4% |
| Date | P/E |
| 2025-03-18 | -0.04 |
| 2025-03-17 | -0.04 |
| 2025-03-14 | -0.04 |
| 2025-03-13 | -0.03 |
| 2025-03-12 | -0.03 |
| 2025-03-11 | -0.03 |
| 2025-03-10 | -0.03 |
| 2025-03-07 | -0.04 |
| 2025-03-06 | -0.04 |
| 2025-03-05 | -0.04 |
| 2025-03-04 | -0.04 |
| 2025-03-03 | -0.04 |
| 2025-02-28 | -0.04 |
| 2025-02-27 | -0.04 |
| 2025-02-26 | -0.04 |
| 2025-02-25 | -0.04 |
| 2025-02-24 | -0.04 |
| 2025-02-21 | -0.04 |
| 2025-02-20 | -0.05 |
| 2025-02-19 | -0.05 |
| 2025-02-18 | -0.04 |
| 2025-02-14 | -0.04 |
| 2025-02-13 | -0.04 |
| 2025-02-12 | -0.04 |
| 2025-02-11 | -0.04 |
| 2025-02-10 | -0.04 |
| 2025-02-07 | -0.05 |
| 2025-02-06 | -0.05 |
| 2025-02-05 | -0.05 |
| 2025-02-04 | -0.05 |
| 2025-02-03 | -0.04 |
| 2025-01-31 | -0.05 |
| 2025-01-30 | -0.04 |
| 2025-01-29 | -0.04 |
| 2025-01-28 | -0.04 |
| 2025-01-27 | -0.06 |
| 2025-01-24 | -0.05 |
| 2025-01-23 | -0.06 |
| 2025-01-22 | -0.05 |
| 2025-01-21 | -0.05 |
| 2025-01-17 | -0.05 |
| 2025-01-16 | -0.05 |
| 2025-01-15 | -0.04 |
| 2025-01-14 | -0.06 |
| 2025-01-13 | -0.05 |
| 2025-01-10 | -0.05 |
| 2025-01-08 | -0.05 |
| 2025-01-07 | -0.04 |
| 2025-01-06 | -0.04 |
| 2025-01-03 | -0.04 |